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Chlamydia trachomatis, an obligate intracellular bacterium, intercepts different trafficking
pathways of the host cell to acquire essential lipids for its survival and replication,
particularly from the Golgi apparatus via a Rab14-mediated transport. Molecular
mechanisms underlying how these bacteria manipulate intracellular transport are a
matter of intense study. Here, we show that C. trachomatis utilizes Akt/AS160 signaling
pathway to promote sphingolipids delivery to the chlamydial inclusion through Rab14-
controlled vesicular transport. C. trachomatis provokes Akt phosphorylation along its
entire developmental life cycle and recruits phosphorylated Akt (pAkt) to the inclusion
membrane. As a consequence, Akt Substrate of 160 kDa (AS160), also known as
TBC1D4, a GTPase Activating Protein (GAP) for Rab14, is phosphorylated and therefore
inactivated. Phosphorylated AS160 (pAS160) loses its ability to promote GTP hydrolysis,
favoring Rab14 binding to GTP. Akt inhibition by an allosteric isoform-specific Akt
inhibitor (iAkt) prevents AS160 phosphorylation and reduces Rab14 recruitment to
chlamydial inclusions. iAkt further impairs sphingolipids acquisition by C. trachomatis-
inclusion and provokes lipid retention at the Golgi apparatus. Consequently, treatment
with iAkt decreases chlamydial inclusion size, bacterial multiplication, and infectivity
in a dose-dependent manner. Similar results were found in AS160-depleted cells. By
electron microscopy, we observed that iAkt generates abnormal bacterial forms as those
reported after sphingolipids deprivation or Rab14 silencing. Taken together, our findings
indicate that targeting the Akt/AS160/Rab14 axis could constitute a novel strategy to
limit chlamydial infections, mainly for those caused by antibiotic-resistant bacteria.
Keywords: Chlamydia trachomatis, Akt/AS160 signaling pathway, Rab14, Golgi-derived sphingolipids, Rab
proteins, GTPase activating proteins, vesicular transport
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INTRODUCTION
Chlamydia trachomatis (C. trachomatis), a Gram-negative
obligate intracellular pathogen, is the most frequent cause of
bacterial sexually transmitted diseases worldwide (WHO, 2014).
Chlamydial infections are a serious problem in reproductive
health. Most of the cases are asymptomatic, which lead to
undiagnosed and untreated infections. Consequently, a chronic
course is the common feature underlying inflammation and
scarring responsible for undesirable complications such as tubal
obstruction, ectopic pregnancy and infertility among young
women (Luján et al., 2016; Tsevat et al., 2017).
Chlamydia trachomatis invades human cervical epithelial cells
through different receptors and displays effective molecular
mechanisms to promote its internalization (Clifton et al.,
2004; Cossé et al., 2016; Lujan et al., 2018). Once inside
the host cell, C. trachomatis replicates in a modified vacuole
called inclusion. Its biphasic developmental cycle involves two
bacterial forms: infectious non-replicative elementary bodies
(EBs), and non-infectious replicant-competent metabolically
active reticulate bodies (RBs) (Bastidas et al., 2013; Vromman
et al., 2014). Under stressing conditions, such as sustained
treatment with penicillin (Cevenini et al., 1988), gamma-
interferon (INFγ) (Beatty et al., 1993, 1994a) and nutrients
or sphingolipids deprivation (Raulston, 1997; Robertson et al.,
2009; Capmany and Damiani, 2010), reticulate bodies acquire
abnormal characteristics. Aberrant bacteria (AB) are non-
infectious non-replicative forms with low metabolic activity.
AB can remain inside host cells for years, being typical of
persistent chlamydial infections associated with detrimental
consequences for human fertility (Beatty et al., 1994b; Witkin
et al., 2017). When stressing conditions disappear, AB re-
enter the normal developmental cycle. After several rounds
of asynchronous replication, RBs differentiate back into EBs.
Finally, bacteria are released either by host cell lysis or extrusion
of inclusions to spread the infection to neighboring cells
(Hybiske and Stephens, 2007).
Chlamydia trachomatis has developed multiple strategies to
manipulate molecular controllers of intracellular trafficking to
escape from the degradative phagocytic pathway and to piracy
biosynthetic routes (Hackstadt et al., 1995; Damiani et al., 2014).
This way, C. trachomatis creates a favorable environment that
helps it to avoid immune responses (Cunha and Zamboni, 2013;
Rajeeve et al., 2018) and, simultaneously allows the acquisition
of needed host molecules for bacterial growth and replication
(Saka and Valdivia, 2010). C. trachomatis obtains amino acids,
nucleotides, and lipids from the host cell (van Ooij et al.,
2000; Saka and Valdivia, 2010; Mehlitz et al., 2017). Particularly,
sphingomyelin, cholesterol, and neutral lipids are obtained by
hijacking TGN-derived vesicles (Hackstadt et al., 1995, 1996;
Carabeo et al., 2003), multivesicular bodies (Beatty, 2006, 2008;
Gambarte Tudela et al., 2015) and lipid droplets, respectively
(Kumar et al., 2006; Cocchiaro et al., 2008).
Rab proteins, a family of small GTPases, play a key role in
the regulation of vesicular transport (Pfeffer, 2017); and some
of these enzymes have been implicated in chlamydial inclusion
development (Damiani et al., 2014). C. trachomatis recruits
Rab1, Rab4, Rab6, Rab11, Rab14, and Rab39a to the inclusion
membrane (Rzomp et al., 2003, 2006; Rejman Lipinski et al.,
2009; Capmany and Damiani, 2010; Leiva et al., 2013; Gambarte
Tudela et al., 2015). We have demonstrated that Rab14, which
controls transport from the Golgi apparatus to early endosomes
and the plasma membrane, is involved in sphingolipids delivery
to the chlamydial inclusion (Capmany and Damiani, 2010;
Capmany et al., 2011).
Rab GTPases are active in the GTP-bound state and
inactive when associating to GDP (Pfeffer, 2017). Several
proteins assist Rabs in their GTP/GDP cycling: (i) Guanine
nucleotide Exchange Factors (GEFs) that exchange GDP
for GTP, turning Rabs into their active state; and (ii)
GTPase Activating Proteins (GAPs) which increase the intrinsic
hydrolytic activity of Rab proteins, favoring the inactive GDP-
bound state (Zerial and McBride, 2001). Phosphatidylinositol-
3-kinase (PI3K)/Akt/AS160 signaling pathway arises as a novel
regulator of Rab GTP/GDP cycling. It has been extensively
studied in adipocytes and muscle cells (Klip et al., 2014). Akt
kinase, upon activation, phosphorylates and inactivates AS160
which is GAP for Rab2, Rab8A, Rab10, and Rab14 (Mîinea et al.,
2005; Ishikura et al., 2006). Consequently, Rab proteins hydrolyze
GTP more slowly and remain in the active state for longer time.
The link between Akt/AS160 pathway and Rab function has been
well described in the transport of GLUT4-containing vesicles to
the plasma membrane after insulin stimulus (Klip et al., 2014) and
in aquaporin-2 translocation to the membrane of renal collecting
ducts (Jung and Kwon, 2010). Noteworthy, some bacteria like
Salmonella typhi usurps PI3K/Akt pathway to avoid fusion with
lysosomes by altering Rab proteins function, and at the same
time, to control actin dynamics mediated by RhoA and Rac1
during bacteria internalization (Kuijl et al., 2007).
Chlamydia trachomatis resides inside the boundaries of the
inclusion, from where it actively interacts with the host cell by
exporting various effector proteins via a type three secretion
system, either into host cytoplasm or integrated into the inclusion
membrane. Some of these bacterial proteins -like translocated
early phospho-protein (TepP) and other still unidentified factors-
target PI3K signaling pathway to control glucose metabolism,
cell growth and proliferation, genome stability and transcription,
and survival of host cell (Verbeke et al., 2006; Rajalingam et al.,
2008; Siegl et al., 2014; Subbarayal et al., 2015; Carpenter et al.,
2017). Downstream of PI3K is the serine/threonine kinase Akt,
also known as protein kinase B, whose activation is controlled
by two main phosphorylation sites: Thr-308 and Ser-473 (Alessi
et al., 1997; Sarbassov, 2005). Several reports described PI3K/Akt
involvement in different aspects of chlamydial infection like
invasion (Lane et al., 2008; Patel et al., 2014; Subbarayal et al.,
2015), apoptosis resistance and bacterial development (Verbeke
et al., 2006; Rajalingam et al., 2008; Gurumurthy et al., 2010;
Subbarayal et al., 2015). Akt participates in multiple signaling
pathways (Huang et al., 2018), however, despite advances
achieved to unravel its role in chlamydial infection, many gaps
remain unsolved. Here, we demonstrate a link between Akt
activation and intracellular transport in C. trachomatis-infected
cells. The bacterium hijacks Akt/AS160 pathway as a strategy to
ensure the recruitment of Rab14-positive vesicles to chlamydial
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inclusions for seizing Golgi-derived sphingolipids. Accordingly,
Akt inhibition restores AS160 GAP activity, which restricts
Rab14-mediated sphingolipids delivery to chlamydial inclusions,




HeLa 229 cells (ABAC, Bs.As., Argentina) were grown in high
glucose Dulbecco’s modified Eagle’s medium (D-MEM) (GIBCO-
BRL, Bs.As., Argentina) supplemented with 10% fetal bovine
serum (FBS) (Internegocios SA, Bs. As., Argentina). Cells were
routinely checked for Mycoplasma contamination by PCR (van
Kuppeveld et al., 1992). C. trachomatis serovar L2 434/Bu (Ct)
(gently given and typified by Unidad de Estudios de Chlamydias,
FFyB, UBA, Bs. As., Argentina) and C. trachomatis strain
harboring p2TK2-SW2 IncDProm-RSGFP-IncDTerm serovar L2
(GFP-Ct) (kindly provided by Isabelle Derré) (Agaisse and Derré,
2013) were used. For bacterial propagation, HeLa cells were
infected at a multiplicity of infection (MOI) of 20 and incubated
at 37◦C in an atmosphere of 5% CO2 and 95% humidified air
for 48 h. Then, infected cells were scrapped in Hanks medium
(0.137 M NaCl, 5.4 mM KCl, 0.25 mM Na2HPO4, 0.44 mM
KH2PO4, 1.3 mM CaCl2, 1.0 mM MgSO4, 4.2 mM NaHCO3).
The cell suspension obtained was incubated in an ultrasound bath
for 5 min. Subsequently, the lysate was centrifuged at 4◦C for
15 min at 500 rpm to remove cell debris. EBs in the supernatant
were purified as previously described (Capmany and Damiani,
2010). Purified EBs were suspended in 0.2 M sucrose-5% FBS-
0.02 M phosphate buffer (pH = 7.2) and titered by assessing
the number of inclusion forming units (IFUs) per microliter as
previously described (Capmany and Damiani, 2010).
Antibodies, Plasmids, and Reagents
In this study, we used the following antibodies: rabbit
polyclonal anti-MOMP coupled to FITC (DakoCytomation, Ely,
United Kingdom); mouse monoclonal anti-MOMP (Santa Cruz);
rabbit polyclonal anti-CT529 (gently provided by Agathe Subtil,
Pasteur Institute, Paris, France); rabbit polyclonal anti-Rab14
(Abcam, ab40938, United States); mouse monoclonal anti-Rab14
(Santa Cruz Biotechnology, sc-271401, United States); rabbit
polyclonal anti-Akt (pan) (Cell Signaling, 4685, United States);
rabbit polyclonal anti-phosphorylated Akt (Ser-473) (Cell
Signaling, 4060, United States); rabbit polyclonal anti-AS160
(pan) (Cell Signaling, 26705, United States); rabbit polyclonal
anti-phosphorylated AS160 (Ser-318) (Cell Signaling, 8619,
United States); mouse monoclonal anti-GM130 (BD Biosciences
610823, United States); mouse monoclonal anti-actin (Abcam,
ab3280, United States); mouse monoclonal anti-clathrin (Santa
Cruz, United States); goat anti-mouse HRP-conjugated IgG
and goat anti-rabbit HRP-conjugated IgG, donkey anti-rabbit
Cy5-labeled IgG, donkey anti-mouse Cy3- or Cy5-labeled IgG,
goat anti-rabbit Cy3-, Cy5- or FITC-labeled IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA, United States
and Invitrogen, Bs. As. Argentina). Plasmids used were pEGFP,
pEGFP-Rab14 WT (gently provided by Dr. Alfred Nordheim,
University of Tuebingen, Tuebingen, Germany), pCherry-Rab14
WT (subcloned at our lab) and pEGFP-RUFY1 (kindly given by
Dr. Shin, Faculty of Pharmaceutical Sciences, Kyoto University,
Japan). To inhibit Akt, infected cells were incubated with
2, 5, or 10 µM of Akt Inhibitor VIII Isozyme-Selective
Akti-1/2 (iAkt) (Sigma, 124018, Bs. As., Argentina) for the
indicated post-infection times (pi). Dimethyl sulfoxide (DMSO)
(Merck, Bs. As., Argentina) was used for control conditions.
Degradative compartments were visualized by incubation with
DQTM bovine serum albumin (DQ-BSA) (Invitrogen, D12051,
Bs. As., Argentina). Hoechst 33258, propidium iodide (PI) and
DAPI were used for nucleic acids staining (Life Technologies, Bs.
As., Argentina).
Cell Transfection, Gene Silencing and
Infection
HeLa 229 cells were grown on 12-mm-diameter glass coverslips
in 24-well plates (ETC Internacional, Bs. As., Argentina) until
70% confluence. Cells were washed once with PBS and serum-
free D-MEM (GIBCO-BRL Bs. As., Argentina) was added. Then,
cells were transfected with Lipofectamine 2000 (Invitrogen, Bs.
As., Argentina) using 1 µl per 1 µg of DNA per well according
to the manufacturer’s protocol. At 24 h post-transfection, cells
were infected with C. trachomatis (Ct or GFP-Ct; MOI 0.5–5).
Bacteria were added to HeLa cells, plates were centrifuged for
15 min at 4◦C at 1,000 rpm and then maintained for 2 h at 37◦C.
After that, cells were washed three times with PBS to eliminate
non-internalized bacteria, and finally, cells were incubated in the
presence of infection medium (D-MEM without antibiotics) at
37◦C in an atmosphere of 5% CO2 and 95% humidified air for
the indicated times (post-infection period).
To knock-down AS160, HeLa cells were transfected in
either 6-well plates or 12-well plates with siRNA-AS160 or
siRNA-Luciferase (control cells) (25 nM final concentration)
(Thermo Scientific Dharmacon, J021230-10, United States)
using Lipofectamine RNAi MAX Transfection Reagent (5 µL;
Invitrogen, Bs. As., Argentina). At 24 or 48 h post-transfection,
depending on the assay, cells were infected with C. trachomatis, as
described above, and incubated for the indicated periods of time
for further manipulations.
Immunoblotting
For western blots, protein extracts were generated by lysing
cells in the presence of protease inhibitor cocktail p-2714
(Sigma-Aldrich, United States). Protein levels were quantified
by Bradford’s method (Tetrahedron, Bs. As., Argentina). Equal
amounts of proteins were resolved in 12% acrylamide SDS-
PAGE gels. Separated proteins were transferred onto 0.45 µm
nitrocellulose membranes (Amersham, Germany) and incubated
overnight with the corresponding primary antibodies followed
by goat anti-rabbit HRP-conjugated IgG (1:5000). Primary
antibodies were rabbit polyclonal anti-Akt (pan) (1:1000),
rabbit polyclonal anti-phosphorylated Akt (Ser-473) (1:1000),
rabbit polyclonal anti-AS160 (pan) (1:1000), rabbit polyclonal
anti-phosphorylated AS160 (Ser-318) (1:1000). Protein loading
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was assessed with monoclonal mouse anti-actin (1:1000) or
monoclonal mouse anti-clathrin (1:1000) followed by goat
anti-mouse HRP-conjugated IgG (1:5000). An Amersham ECL
PlusTM kit was used to detect HRP activity (GE Healthcare Life
Sciences, Bs. As., Argentina) in an ImageQuant LAS4000.
Subcellular Fractionation
Cell fractionation assay protocol was modified from previous
reports (Chua and Wong, 2013). Cells were harvested
by trypsinization and washed with PBS. Then, cells were
resuspended in 400 µl homogenizing buffer (8.6% saccharose,
25 mM HEPES pH 7.4, 5 mm MgCl, 1 mM EDTA, protease
inhibitor 1x). Cells were lysed using 10 passes through a
22-gauge needle followed by 15 min incubation on ice. The
homogenate was clarified by a 400 × g centrifugation for 5 min.
The clarified homogenate was centrifuged at 100,000 × g for
2 h at 4◦C (Optima TLX Ultracentrifuge, Beckmann Coulter).
The cytosol fraction (supernatant) was separated from the
membrane fraction (pellet) before the latter was resuspended
with lysis buffer supplemented with protease inhibitors 1x. Both
fractions were sonicated three times in a 5-s pulse at 10 Amp
on ice. Cytosol and membrane fractions were incubated on ice
for 1 h before a final centrifugation of 16,000 × g for 15 min.




For immunofluorescence staining, formaldehyde-fixed cells were
washed three times with PBS, incubated with 50 mM NH4Cl and
permeabilized in PBS 0.2%/BSA 0.05%/saponin. Cells were then
incubated with the primary antibody for 1 h, washed in PBS and
incubated with FITC-, Cy3-or Cy5-coupled secondary antibodies
(Jackson ImmunoResearch and Invitrogen). As for mounting
medium 1 µg/mL Hoechst or DAPI/Mowiol (Molecular Probes,
United States) was used. Immunofluorescence images were
acquired by confocal microscopy using an Olympus FV FV-
1000 and 10-ASW 1.7 software (Olympus, United States). Images
were processed using Adobe Photoshop CS5, Adobe Illustrator




Infected cells grown on 12-mm-diameter glass coverslips in 24-
well plates were treated with iAkt for the indicated periods
of time; and before its fixation, cells were incubated with
5 µM BODIPY TR ceramide-BSA complex in DMEM or
BODIPY FL ceramide-BSA (Molecular Probes, United States)
for 30 min at 4◦C, then washed 3 times with PBS, and
finally, maintained in DMEM without FBS for 30 min at 37◦C.
Confocal images were captured using the same parameters
setting: equal optical magnification (606) and electronic zoom
(26), identical laser potency (5%), identical photodetector gain
(HV 480 V), identical scanning speed (12 ms/pixel). An Olympus
FV-1000 spectral confocal unit mounted on an IX-25 Olympus
inverted microscope was used. Confocal images were acquired
at 512 by 512 pixels and analyzed with the FV10-ASW 1.7
Software (Olympus America, Inc., Melville, NY, United States).
Fluorescence intensities of TR labeled lipids (635 nm laser) were
determined by defining regions of interest (ROI) coincident
with chlamydial inclusions (405 nm laser) or Golgi apparatus
(delimited by GM130 labeling) by MacBiophotonic Image J and
were expressed as arbitrary units (a.u.). Images were processed
using Adobe Photoshop CS5 and Adobe Illustrator CS5 (Adobe
Systems, Inc., San Jose, CA, United States).
Thin Layer Chromatography of Lipids
Extracts
HeLa cells were infected with C. trachomatis for 48 h. For
the last 24 h of infection, cells were incubated in DMSO,
or 2 µM or 10 µM iAkt. Cell lipid extraction and thin
layer chromatography (TLC) were carried out as previously
described (Capmany and Damiani, 2010). Before harvesting,
cells were incubated for 30 min with BODIPY TR ceramide
at 4◦C in serum-free DMEM. Then, cells were washed with
PBS and incubated with DMEM supplemented with FBS
for 30 min at 37◦C. Cells were subjected to Bligh and
Dyer chloroform:methanol lipid extraction. A portion of the
lipid samples were resuspended in 1:1 chloroform:methanol
and fluorescently labeled lipids were quantified (530 nm
excitation/620 nm emission, Packard FluoroCountTM Microplate
Fluorometer, United States). The remaining of the samples
were resuspended in chloroform/methanol/HCl (100:100:1, v/v)
and resolved on TLC plates using 1- butanol/methanol/acetic
acid/water (8:2:1:2, v/v) as solvent system. Equal amounts
of lipids were seeded. Fluorescent spots were visualized on
air-dried plates upon 550 nm excitation in a LAS- 4000
EPUV luminometer and LAS image reader software (FUJI Life
Science, Japan).
Transmission Electron Microscopy
HeLa cells grown in T-25 mL flasks were infected with
C. trachomatis L2 (Ct; MOI of 5) and treated with 5 µM iAkt from
2 h pi until its fixation at 24 h pi. Infected cell monolayers were
fixed with 2% glutaraldehyde/PBS for 1 h at 37◦C. Then, cells
were removed with 1% gelatin/PBS, gently centrifuged (15 min at
1200 rpm) and washed three times with PBS. After that, cells were
incubated with Osmium tetroxide/Potassium ferricyanide/PBS
(1:1:1) for 90 min. Samples were dehydrated using increasing
acetone series and embedded in Spurr’s resin (Ted Pella Inc.,
United States). Thin sections were cut with an ultramicrotome
(Leica ultracut R, Austria) and stained with 1% uranyl acetate
and Reynold’s lead citrate (Ted Pella Inc., United States) before
they were observed with a Zeiss 900 electron microscope (Zeiss,
Germany). Images were processed using Adobe Photoshop CS5
(Adobe Systems, Inc., San Jose, CA, United States).
Flow Cytometry
Cell viability was assessed after iAkt treatment (10 µM, 24 h)
or FBS starvation (4 h or 24 h) by incubation with zombie NIR
fixable probe (BioLegend Co.) for 30 min as indicated in the
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manufacturer’s protocol. To evaluate bacterial replication, HeLa
cells were infected with GFP-Ct and increasing concentrations
of iAkt were added from 2 h pi until its fixation at 24 h pi.
Cell-associated fluorescence was quantified in a BD FACSAria
III (Becton Dickinson Biosciences). FlowJoTM software was used
to analyze data.
Inclusion Forming Units
Inclusion Forming Units (IFUs) per microliter were assessed as
previously described (Capmany and Damiani, 2010). Briefly, to
analyze the effect of Akt inhibition on the yield of chlamydial
infectious progeny, HeLa cells were infected with C. trachomatis
and 2 h later, cells were treated with iAkt (2, 5, or 10 µM) or
DMSO for the control condition. Cells were incubated for 48 h,
lysed and scrapped in SPG buffer. Then, serial dilutions of EBs
were inoculated onto HeLa cells seeded on 96-well plates. After
24 h, cells were fixed, permeabilized and stained with FITC-
coupled anti-MOMP antibodies. Inclusions were visualized and
counted in 30 fields using a T-2000 Nikon epifluorescence
microscope (Nikon, Japan), and expressed as IFUs per µL.
Statistical Analysis
Data were statistically analyzed by Student’s t-test, or one-
way ANOVA and Bonferroni post-test, as indicated in each




Phosphorylation Causes Its Intracellular
Redistribution
Previous reports show discrepancy in Akt phosphorylation
during infection, likely due to differences in Chlamydia species
or serovars, experimental conditions or periods of infection
(Verbeke et al., 2006; Lane et al., 2008; Rajalingam et al.,
2008; Gurumurthy et al., 2010; Patel et al., 2014; Siegl
et al., 2014; Subbarayal et al., 2015; Carpenter et al., 2017).
Therefore, we monitored Akt expression and phosphorylation
in C. trachomatis-infected cells along the whole bacterial
developmental cycle. Akt and phosphorylated Akt (pAkt)
were measured by western blot in a time course assay. To
avoid Akt phosphorylation induced by components of FBS,
most experiments have been performed after 4 h of FBS
deprivation unless when used as positive control of Akt pathway
activation (Watton and Downward, 1999). Cell viability was
not affected by 4 h or 24 h of FBS starvation (Supplementary
Figure S1). Although Akt phosphorylation and consequent
activation occurred at every time post-infection (pi), we identified
three main peaks of phosphorylation: at the beginning (2 h pi), at
the middle (8 h pi), and at later stages (36 h pi) of the bacterial
developmental cycle (Figure 1A). Figure 1B shows the ratio of
phosphorylated Akt (pAkt) in Chlamydia-infected cells related to
uninfected cells at different post-infection times. At the peaks,
pAkt doubled or tripled the basal level of Akt phosphorylation
in uninfected cells (Figure 1B). In contrast, total Akt expression
levels remained unaltered after infection, regardeless of post-
infection times (data not shown and Patel et al., 2014). Next, we
assessed whether Akt intracellular distribution was altered. HeLa
cells were infected with C. trachomatis and fixed at 8 h pi, at
mid-stage Akt phosphorylation peak. Then, pAkt was detected
by immunofluorescence using antibodies that recognize Akt
phosphorylated on residue Ser-473. Remarkably, infection with
C. trachomatis caused a dramatic redistribution of endogenous
pAkt that concentrated at the perinuclear region where these
bacteria localized, suggesting pAkt recruitment to chlamydial
inclusion membranes (Figure 1C). Overall, Akt phosphorylation
and association with inclusions supports the notion that it may
play a role in chlamydial infection.
An Allosteric Isoform-Specific Akt
Inhibitor Reduces Chlamydial Inclusion
Growth
To unravel the effect of Akt phosphorylation in the course of
infection, we assayed an allosteric Akt inhibitor (iAkt) which
is isoform-selective against Akt 1 and Akt 2 and possesses
high specificity compared to ATP-competitive inhibitors that
also target closely related kinases due to similarities in
catalytic domains (Pentassuglia et al., 2016; Ebner et al., 2017;
Mousset et al., 2018). The ability of iAkt to block the kinase
phosphorylation and consequently its activation was assessed by
western blot. Uninfected cells incubated with or without FBS,
and C. trachomatis-infected cells maintained without FBS were
treated with iAkt for 4h before pAkt detection (Figure 2A).
It has been shown that the activation of Akt mediates actin
remodeling required for the invasion process (Ganesan et al.,
2004), therefore, we proved the efficiency of iAkt by infecting
HeLa cells in presence or absence of 5 µM iAkt. Cells were fixed
at 24 h pi and analyzed by confocal microscopy. Akt inhibition
resulted in a significant decrease in bacterial internalization
(Supplementary Figure S2). With the aim of analyzing the iAkt
effect on C. trachomatis growth and development rather than in
the number of invading bacteria, we decided to add the iAkt at 2 h
pi in all the following experimental procedures in order to avoid
interfering with the uptake process.
Briefly, green fluorescent protein (GFP)-overexpressing HeLa
cells infected with C. trachomatis were incubated with increasing
concentrations of iAkt until fixation at 24 h pi. Hoechst stained
nuclei and bacterial DNA. Confocal images showed that as
the concentration of Akt inhibitor increased, inclusions became
smaller. GFP expression facilitated the visualization of chlamydial
inclusions as black holes within infected cells since, inclusion
membrane acts as a restrictive barrier for this soluble fluorescent
protein (Boncompain et al., 2014). Maximal growth inhibition
was achieved at 10 µM, reaching a decrease of approximately 50%
in inclusion size (Figures 2B,C). These results further confirm the
importance of Akt phosphorylation for bacterial development.
By flow cytometry, we determined that host cell viability was
unaltered after iAkt treatment, even at the higher doses of the
inhibitor (10 µM, 24 h, 37◦C) (Supplementary Figure S1).
Alternatively, downsizing of inclusions by iAkt treatment may
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FIGURE 1 | Chlamydia trachomatis (Ct) phosphorylates Akt and modifies its subcellular distribution. (A) HeLa cells were infected with Ct (MOI 1) for the indicated
periods of time. Uninfected cells were used as control (C). Akt expression and phosphorylation was evaluated by immunoblot with anti-Akt and anti-pAkt antibodies,
respectively. Actin was used as loading control. Cells were serum starved 4 h before sampling. Blots are representative of at least three independent experiments.
(B) Relative phosphorylation level of Akt in Ct-infected cells compared to pAkt in uninfected cells. (C) HeLa cells were infected with C. trachomatis overexpressing
the green fluorescence protein (Ct-GFP) (MOI 0.5) for 8 h and serum starved the last 4 h before fixation. Uninfected cells (C) incubated either with or without FBS
served as control. Localization of phosphorylated Akt (pAkt) was detected by confocal microscopy with rabbit anti-pAkt (S473) followed by Cy3-coupled anti-rabbit
antibodies. DNA was stained with DAPI. Arrow indicates chlamydial inclusions. Images are representative of three independent experiments.
be attributed to direct drug toxicity to the bacteria causing
their killing by targeting to the phagocytic pathway. To explore
whether bacteria reached degradative compartments, we used a
derivative of albumin called DQ-Albumin which acquires red
fluorescence when it is hydrolyzed. HeLa cells overexpressing
GFP were infected with C. trachomatis and treated with 10 µM
of iAkt from 2 h pi until fixation at 24 h pi, DQ-albumin
was added for the last 18 h of incubation. Confocal images
show that in every cell, fluorescent albumin was not present
within inclusions, indicating that even when bacterial growth
was impaired, C. trachomatis was actively avoiding lysosomal
or other types of degradation, since they remained inside a
non-degradative vacuole (the inclusion). In addition to this, we
found in every infected cell small vesicles likely lysosomes or
late endosomes that preserved their degradative ability evinced
by DQ-albumin red fluorescence, which served as a proper
internal positive control (Figure 2D). Likely, iAkt was acting as
a bacteriostatic agent rather than a bactericidal one at the low
concentrations used. To analyze the reversibility of the iAkt effect
on inclusion development, we incubated infected cells with 5 µM
iAkt for 22 h and then removed the inhibitor and incubated the
cells for additional 24 h in medium without the drug, allowing the
inclusion to grow in case the bacteria within it were still alive. As
it is shown in the images, there was a complete recovery of the size
of the inclusions when the inhibitor was removed (Figures 2E,F).
Chlamydial inclusion expansion precedes bacterial replication
(Engström et al., 2015), therefore to directly assess bacterial
viability and development after the strongest iAkt treatment
(10 µM, 24 h, 37◦C), we performed progeny/reinfection assays.
Results show a significant recovery in the amount of infectious
organisms after the removal of the inhibitor, notwithstanding,
the inclusion forming units did not reach the levels of untreated
cells (Figure 2G). On one hand, we determined that iAkt, at the
concentrations assayed, does not cause bacterial death and that
its effects are reversible. On the other hand, iAkt, acting as a
bacteriostatic agent, reduces the chlamydial inclusion growth and
bacterial replication in a dose-dependent manner.
AS160 Is Inactivated by Akt in
Chlamydia-Infected Cells
Akt acts on more than 35 substrates; being AS160 one of these
downstream targets (Huang et al., 2018). AS160 is a GAP that
promotes its cognate Rab GTPases to hydrolyze GTP and remain
GDP loaded in their inactive state. AS160 can be phosphorylated
on several serine/threonine residues; further Akt-dependent
AS160 phosphorylation abrogates its GAP activity (Ishikura
et al., 2006; Mafakheri et al., 2018). First, we determined if
C. trachomatis infection was able to cause AS160 phosphorylation
and/or modify AS160 expression along the entire bacterial
developmental cycle. Phosphorylated AS160 (pAS160) was
detected by an antibody that recognizes the phosphorylated
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FIGURE 2 | Inhibition of Akt impairs chlamydial inclusion growth. (A) Uninfected cells (C) incubated either in the presence or absence of serum (FBS) and serum
starved Ct-infected cells (MOI 1) were treated with iAkt (10 µM) or DMSO the last 4 h before sampling at 8 h pi. Akt phosphorylation was evaluated by immunoblot.
Actin was used as loading control. (B) GFP overexpresing HeLa cells were infected with Ct (MOI 1). At 2 h later, increasing concentrations of iAkt (2, 5, and 10 µM)
or DMSO were added until fixation at 24 h pi. Inclusions are pointed out with asterisks. Bars represent 10 µm. (C) Quantification of chlamydial inclusion area of 100
cells from three independent experiments was performed with ImageJ. Data are the mean ± SEM (∗∗∗p < 0.001). (D) GFP overexpressing cells infected with Ct
(MOI 2) were incubated with iAkt (10 µM) from 2 h pi until fixation at 24 h pi. DQ-albumin was added during the last 18 h of incubation. Images were analyzed by
confocal microscopy. Arrow indicates chlamydial inclusions. Bars represent 10 µm. (E) Four sets of cells were infected with Ct (MOI 1). At 2 h pi, iAkt (5 µM) or
DMSO were added to two plates each. At 24 h pi, a set of cells incubated with iAkt and a set incubated with DMSO were fixated and the remaining two sets of
(Continued)
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FIGURE 2 | Continued
cells were washed out and incubated with fresh medium without drugs for an additional 24 h. DNA was stained with Hoechst. Inclusions are delimited with white
dashed lines (B,D,E). Bars represent 10 µm. (F) Quantification of the experiment above. Data are the mean ± SEM of three independent experiments
(∗∗∗p < 0.001). (G) For a rescue assay, HeLa cells infected with Ct (MOI 1) were incubated with either DMSO (control cells) or 10 µM iAkt (iAkt and rescue). After
24 h pi, medium was renewed, and only in one set of cells was maintained with 10 µM iAkt (iAkt). At 48 h pi, EBs from all conditions (DMSO, iAkt and rescue) were
harvested and infectious progeny was titrated in serial dilutions on HeLa cells. Bacteria were immunodetected with an anti-MOMP antibody coupled to FITC and
inclusion forming units (IFU) were determined. Data are representative of two independent experiments performed in triplicates. Bars and the error bars represent
mean ± SEM (∗∗p < 0.01; ∗∗∗p < 0.001).
residue at Ser-318, which is conveniently involved in the loss of
GAP activity (Sano et al., 2003; Geraghty et al., 2007). By western
blot, we assessed pAS160 and AS160 in HeLa cells infected
with C. trachomatis for different periods of time. Consequently,
we verified a readily observable phosphorylation of AS160 that,
in the absence of fetal bovine serum, increased its magnitude
along chlamydial infection (Figure 3A). To further confirm
C. trachomatis-induced AS160 phosphorylation, we infected
HeLa cells with alive or heat-inactivated bacteria; and at 2 h
pi, we harvested the cells to detect pAS160 by western blot.
Our results showed that viable C. trachomatis induces AS160
phosphorylation more efficiently than dead bacteria. There is
a brief but consistent activation of Akt at the initial steps
of phagocytosis, independently of the pathogen that is being
internalized, or if it is dead or alive. Furthermore, this fact is
also observed during the uptake of any type of beads. This Akt
phosphorylation is related to the actin polymerization that it is
needed for pseudopod extension at the phagocytic cup (Gu et al.,
2003). As activated Akt phosphorylates AS160, dead bacteria-
induced Akt activation produced AS160 phosphorylation at early
stages of infection, as expected. However, pAS160 levels were
substantially higher when cells were infected with alive bacteria
(Figure 3B). To further connect C. trachomatis-induced Akt
activation with AS160 phosphorylation, we explored whether Akt
functions as a kinase for AS160. Uninfected and C. trachomatis-
infected cells were treated with iAkt before analysis of pAS160
by western blot. pAS160 drastically decreased in the presence
of iAkt, indicating that Akt is the main kinase responsible for
AS160 phosphorylation during chlamydial infection (Figure 3C).
Akt exerts its function on AS160 when they are both associated
to the same membrane (Larance et al., 2005; Gonzalez and
McGraw, 2009). In uninfected cells, AS160 is detached from
membranes upon phosphorylation (Thong et al., 2007). For these
reasons, we explored Akt/AS160 association to membranes in
the context of C. trachomatis infection. Briefly, a subcellular
fractionation to separate membranes from cytosol was performed
in uninfected and infected cells. Then, proteins were separated
by PAGE and immunobloted with specific antibodies. Clathrin
was used as a membrane marker whereas actin indicated
the cytosolic fraction. According to previous reports, actin
was partially collected in the membrane fraction due to its
association to the inclusion membrane (Kumar and Valdivia,
2008). Detection of the major outer membrane protein (MOMP)
was indicative of bacteria. As expected by the findings developed
above, we found less bacterial protein after iAkt treatment.
Regarding Akt, infection triggered its phosphorylation, while
the inhibitor blocked it. Interestingly, we found an increase in
the amount of non-phosphorylated AS160 (AS160) associated to
membranes, concominantly to Akt inhibition. Additionally, these
results further confirmed that phosphorylated AS160 (pAS160)
detached from membranes and thus we could not detect it
on the membrane fraction (Figure 3D). To corroborate these
findings, we analyzed by confocal microscopy AS160 subcellular
localization in C. trachomatis-infected cells incubated in the
absence or presence of the Akt inhibitor. In untreated cells,
phosphorylation of AS160 caused its release from membranes,
adopting a cytosolic distribution; whereas in the presence of
iAkt, AS160 remained dephosphorylated and associated with
internal membranes, as expected by its phosphorylation state
(Kane et al., 2002; Larance et al., 2005; Peck et al., 2006). Confocal
images showed smaller chlamydial inclusions, clearly decorated
with AS160, in infected cells treated with iAkt (Figure 3E).
Furthermore, to directly assess the participation of AS160 on
chlamydial infection, HeLa cells, previously transfected with
siRNA-AS160 or siRNA-Luciferase for 48 h, were infected with
C. trachomatis. At 24 h pi, the percentage of infected cells
and the growth of inclusions were determined by confocal
microscopy (Figure 3F). Analysis of AS160 involvement in
bacterial uptake showed that this protein does not participate
in the internalization process (Supplementary Figure S3).
AS160 silencing was confirmed by western blot (Figure 3G).
Nonetheless the lack of effect of AS160 knockdown on the
number of infected cells, our findings indicate that AS160
depletion causes a significant decrease in inclusion size. This
finding is in agreement with previous reports pointing out that
GTP/GDP cycling is essential for Rab function, implying the
participation of AS160 in chlamydial inclusion growth.
Rab14 Recruitment to Chlamydial
Inclusions Is Interfered by Akt/AS160
Pathway Inhibition
Akt-mediated phosphorylation of AS160 abrogates its GAP
activity, leading to the prevailing active state of its downstream
target Rab14 (Ishikura et al., 2006; Brewer et al., 2016). We
have previously shown that C. trachomatis actively recruits
Rab14 to the inclusion membrane along bacterial developmental
cycle (Capmany and Damiani, 2010; Capmany et al., 2011).
Furthermore, we have shown that GTP/GDP cycling is necessary
to accomplish Rab14 function since GDP-bound mutant (GFP-
Rab14 S25N) is retained at the Golgi apparatus in infected cells
(Capmany and Damiani, 2010). Therefore, we decided to analyze
by confocal microscopy the subcellular localization of both
AS160 and Rab14 after C. trachomatis infection. Noteworthy,
Rab14 was observed at the inclusion membrane region where
AS160 was not present (Figure 4A). This finding is in line with
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FIGURE 3 | AS160 is phosphorylated by Akt during infection. (A) HeLa cells were infected with Ct (MOI 1) and serum-starved the last 4 h before sampling. AS160
expression and phosphorylation were evaluated by immunoblot with anti-AS160 and anti-pAS160 antibodies, respectively. Uninfected cells incubated in the absence
(C–) or presence (C+) of FBS were used as a control. Actin indicates the protein load. Blots are representative of three independent experiments. (B) Serum-starved
HeLa cells were incubated during 2 h with living or heat inactivated (10 min in boiling water) bacteria (MOI 5). Uninfected serum-starved cells were used as a control.
AS160 phosphorylation was evaluated by immunoblot. Actin was used as loading control.(C) HeLa cells infected with Ct (MOI 1) for 4 h or 8 h, incubated in DMEM
(Continued)
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FIGURE 3 | Continued
without FBS were treated with DMSO or iAkt (10 µM) the last 4 h of the experimental period. As control, FBS-stimulated uninfected HeLa cells were treated with
DMSO or iAkt for 4 h. AS160 phosphorylation was evaluated by immunoblot. Actin was used as loading control. Blots are representative of three independent
experiments. (D) Infected (24 h pi, MOI 3) and uninfected cells were treated with DMSO or iAkt 10 uM for 22h before harvesting. Subcellular fractionation was
performed to obtain cytosol and membrane fractions. Proteins were solved by PAGE and immunoblotted. Anti-Akt, anti-pAkt, anti-AS160 and anti-pAS160
antibodies were used to assess phosphorylation state of both proteins. Bacterial Major Outer Membrane Protein was detected with Anti-MOMP antibodies.
Anti-clathrin was used as membrane marker, while anti-actin, as cytosolic marker. (E) HeLa cells infected with Ct (MOI 1) were incubated with DMSO or iAkt (10 µM)
from 2 h pi until fixation at 24 h pi. AS160 subcellular localization was detected with rabbit polyclonal anti-AS160 antibodies followed by Cy3-labeled IgG and then
cells were analyzed by confocal microscopy. Asterisks point out inclusions. Bars represent 10 µm. (F) HeLa cells were depleted of AS160 and infected with Ct (MOI
1). Chlamydial inclusion area was analyzed by confocal microscopy. Data are the mean ± SEM of three independent experiments (∗∗p < 0.01) of 100 cells each.
(G) AS160 knockdown was confirmed by western blot. Data are the mean ± SEM of three independent experiments (∗∗∗p < 0.01).
the general concept that active non-phosphorylated AS160 is
associated with membranes where it promotes the hydrolysis of
GTP bound to Rab14, turning the Rab into its inactive soluble
GDP-bound form, thus, favoring the release of Rab14 from the
membrane. On the contrary, when AS160 is phosphorylated,
it is detached from membranes and, consequently, it cannot
exert its GAP activity; hence, Rab14 remains in its active
GTP-bound state associated to the membrane for a longer
time (Mafakheri et al., 2018). As expected, AS160 knock down
detrimentally impacted on chlamydial inclusion development
with the appearance of smaller vacuoles. Hence, impairment of
GTP/GDP cycling affected Rab14 function in transport between
compartments (Supplementary Figure S4). Although implied,
our experiments did not show GTP loading of Rab14. Therefore,
we confirmed Rab14 binding to GTP by its ability to recruit
effectors like RUFY1 that only interacts with Rab14 GTP-
bound form (Yamamoto et al., 2010). On the contrary, after
iAkt treatment, thus, in the case of AS160 exerting its GAP
activity, RUFY1 and Rab14 mostly display a cytosolic pattern
(Supplementary Figure S5).
Next, we analyzed the effect of iAkt on Rab14 recruitment
to chlamydial inclusions. Briefly, HeLa cells infected with
C. trachomatis were treated 2 h later with increasing
concentrations of iAkt or DMSO until fixation at 24 h pi.
Endogenous Rab14 was immunodetected with a specific
antibody and inclusion membrane was marked by labeling the
bacterial protein CT529. Accordingly, Rab14 recruitment to the
inclusion membrane was hindered by iAkt in a dose-dependent
manner. Moreover, treatment with the highest concentration
of Akt leads to the complete dissociation of Rab14 from
the inclusion (Figure 4B). The loss of association with the
inclusion membrane of Rab14 after iAkt treatment, strongly
suggests that Akt/AS160 signaling pathway regulates vesicular
transport controlled by this Rab in C. trachomatis-infected cells.
Likely, C. trachomatis promotes the arrival to the inclusions of
Rab14-vesicles by hijacking PI3K/Akt/AS160 signaling pathway.
Chlamydial Inclusions Fail to Acquire
Golgi-Derived Sphingolipids After Akt
Inhibition
Considering our previous findings that Rab14 mediates
sphingolipids delivery to chlamydial inclusions (Capmany and
Damiani, 2010) together with our current results showing that
Akt inhibition decreases Rab14 recruitment to the inclusions,
we predicted that transport of sphingolipids toward chlamydial
inclusions would be affected by iAkt treatment. To prove this
hypothesis, cells infected with C. trachomatis L2 (Ct) were
incubated with increasing concentrations of iAkt from 2 h pi
until the end of the experimental period. Fluorescent BODIPY
TR ceramide, a sphingomyelin (SM) precursor, was used as
a probe for sphingolipids trafficking (Hackstadt et al., 1995).
Before fixation, cells were incubated with BODIPY TR ceramide
for 30 min at 4◦C, and then, the medium was renewed and
cells were incubated for an additional 30 min period at 37◦C.
Finally, cells were fixed and bacteria were detected by direct
immunofluorescence with a specific antibody against major outer
membrane protein (MOMP) coupled to fluorescein (FITC). In
untreated C. trachomatis-infected cells, there was a complete
overlapping of the fluorescence corresponding to bacteria and
SM. In addition to the decrease in bacterial growth and inclusion
development, there was a significant reduction in sphingolipids
acquisition by chlamydial inclusions after iAkt treatment in
a dose-dependent manner (Figure 5A). At the right side of
the images, representative profiles of fluorescence intensity are
shown. Each profile was obtained by scanning green and red
fluorescence intensities along a line that traverses the indicated
inclusion (Figure 5B). In line with our hypothesis, Akt inhibition
appears to cause sphingolipids retention at the periphery of
chlamydial inclusions. To further analyze this finding, HeLa
cells infected with GFP-expressing C. trachomatis (Ct-GFP)
were treated as described in the experiment above, but in this
case, we labeled the Golgi apparatus by detecting GM130, a
structural Golgi-associated protein. Bacterial and eukaryotic
DNA was stained with DAPI. Images show that SM did not reach
the chlamydial inclusion, being retained at the Golgi apparatus
after Akt inhibition (Figure 5C). Furthermore, blockage of
SM departure from the Golgi apparatus was dependent on
iAkt concentration. Golgi-associated SM fluorescence intensity
was measured by confocal microscopy in every iAkt doses
assayed (Figure 5D). Additionally, we used BODIPY FL
ceramide that shifts fluorescence from 515 nm (green) to
620 nm (red) at increasing concentrations. Experiments were
performed as described above for BODIPY TR ceramide.
Golgi apparatus was detected with GM130 antibodies and
DNA was stained with DAPI. With this different approach,
we confirmed that Akt inhibition reduced the arrival of
sphingolipids to the chlamydial inclusion and caused a readily
observable enrichment of these lipids at the Golgi apparatus
(Supplementary Figure S6).
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FIGURE 4 | Rab14 recruitment to chlamydial inclusions is hindered by Akt/AS160 inhibition. (A) HeLa cells were infected with Ct (MOI 1) for 24 h. Immunodetection
of endogenous AS160 with rabbit antibody followed by Cy5-coupled secondary antibodies. Detection of endogenous Rab14 was performed with mouse antibody
followed by FITC-coupled secondary antibodies. Propidium iodide (PI) stained DNA. (B) Infected cells (MOI 1) were incubated with DMSO or increasing
concentrations of iAkt (2, 5, and 10 µM) from 2 h pi until fixation at 24 h pi. Subcellular distribution of endogenous Rab14 was observed by confocal microscopy
using mouse primary antibody followed by Cy3-conjugated anti-mouse secondary antibody. Inclusion membrane was detected using rabbit anti-CT529 antibody
followed by FITC-conjugated anti-rabbit IgG. DAPI was used to stain DNA. Bars represent 10 µm. Images are representative of three independent experiments.
FIGURE 5 | Sphingolipids transport to the inclusions is interfered by Akt inhibition. (A) Infected cells (MOI 2) were incubated with DMSO or increasing concentrations
of iAkt (2, 5, and 10 µM) from 2 to 24 h pi. Before fixation, cells were incubated for 30 min with Ceramide-BODIPY at 4◦C in serum-free DMEM. Then, cells were
washed with PBS and incubated with DMEM supplemented with FBS for 30 min at 37◦C. Finally, bacteria were detected with anti-MOMP coupled to FITC.
(B) Intensity profiles obtained by scanning red (SM) and green (Ct) fluorescence along a line that crosses inclusions. (C) In experiments conducted as described in
(A), Golgi apparatus was detected with mouse anti-GM130 antibody followed by anti-mouse Cy5-coupled secondary antibody. Bacteria were detected with
anti-MOMP coupled to FITC. DAPI stained nuclei (N) and bacterial DNA. Concentration and localization of sphingolipids are depicted in the bottom panels. Fire scale
represents the fluorescence intensity associated to sphingolipids. Golgi apparatus is delimited with a white line. (D) Fluorescence intensity corresponding to
sphingolipids at the Golgi apparatus was quantified using ImageJ. Data are representative of three independent experiments (∗∗∗p < 0.001, ∗∗p < 0.01).
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FIGURE 6 | Disruption of the Akt/AS160 pathway causes retention of lipids at the Golgi apparatus. (A) Equal amounts of lipids extracted from infected cells
incubated with DMSO, 2 µM or 10 µM iAkt were resolved by thin layer chromatography (TLC). A representative TLC from two independent experiments is shown.
(B) HeLa cells were transfected with either siRNA-Luc or siRNA-AS160 and, 48 h later, infected with GFP-expressing C. trachomatis (MOI of 1). AS160-silenced and
control cells were incubated with DMSO or increasing concentrations of iAkt (2 or 10 µM). After 24 h of infection and before fixation, cells were incubated for 30 min
with BODIPY TR ceramide at 4◦C in serum-free DMEM. Then, cells were washed with PBS and incubated with DMEM supplemented with FBS for 30 min at 37◦C.
Golgi apparatus was immunodetected in fixed cells with mouse anti-GM130 monoclonal antibody followed by Cy5 coupled anti-mouse secondary antibody. Bars
show the average fluorescence intensity of lipids at the Golgi apparatus. ImageJ was used for this analysis. (C) Representative images of two independent
experiments performed as indicated in (B). In the upper panels, subcellular distribution of sphigolipids appears in red. GFP expressing bacteria are shown in green.
Golgi was stained with mouse anti-GM130 followed by anti-mouse Cy5-coupled secondary antibody (white). In the lower panel, fire scale represents the
fluorescence intensity associated to sphingolipids. White lines demarcate Golgi structures. Nuclei were stained with DAPI. Asterisks indicate inclusions.
Next, we analyzed whether Akt inhibitor modifies type
or concentration of fluorescent lipids of cells incubated with
BODIPY TR ceramide. By thin layer chromatography (TLC), we
observed that there was the same fluorescent lipid species within
untreated (DMSO) cells or in cells after treatment with 2 µM or
10 µM iAkt (Figure 6A). We further confirmed that the observed
phenomenon was due to a trafficking defect by the analysis
of lipids distribution and dynamics in AS160-depleted cells, in
which Akt was not inhibited. Images showed that the fluorescent
lipid was retained at the Golgi apparatus not only after treatment
with the Akt inhibitor but also after AS160 silencing. Moreover,
Akt inhibition in AS160-depleted cells did not significantly
increase fluorescent lipid retention at the Golgi, indicating that
Akt acts upstream from AS160 in this cascade (Figures 6B,C).
Taken together, the lack of lipids within chlamydial inclusions is
a consequence of its retention at the Golgi apparatus after Akt
inhibition or AS160 silencing, constituting a trafficking defect
and not an alteration of lipid metabolism.
Finally, involvement of Akt activity in the control of Rab14-
mediated delivery of sphingomyelin to the chlamydial inclusions,
was evaluated in a rescue assay. Briefly, HeLa cells were
transfected with either GFP or GFP-Rab14WT 24 h prior
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infection. Cells were infected for 24 h (MOI 5). At 2 h pi,
GPF-expressing cells were incubated with the vehicle (DMSO)
or 5 µM iAkt for 22 h; and GFP-Rab14 WT- expressing cells,
with 5 µM iAkt (22 h). As expected, Akt inhibition caused a
decrease in the arrival of sphingolipids to the inclusions in GFP-
overexpressing cells. In contrast, Rab14 overexpression overcame
iAkt effect. Thus, we observed higher fluorescence intensity
within inclusions in Rab14-overexpressing cells, indicating that
a higher amount of lipids reached the inclusions (Figure 7).
Taken together, our findings further support the notion
that C. trachomatis, by hijacking Akt/AS160 signaling pathway,
promotes the redirecting to the inclusion of Golgi-derived Rab14-
vesicles that transport endogenously synthesized sphingolipids.
Therefore, Akt inhibition or AS160 depletion hinders Rab14-
controlled SM delivery from the Golgi to chlamydial inclusions.
Akt/AS160/Rab14 Axis Blockage Impairs
Chlamydial Replication and Infectivity
Host sphingolipids are crucial for C. trachomatis development
and their transport to chlamydial inclusions is regulated by the
Akt/AS160/Rab14 cascade, therefore, we analyzed the impact
of Akt inhibition on overall bacteria fitness. First, HeLa cells
infected with C. trachomatis L2 (Ct) for 24 h and treated with
5 µM iAkt for the last 22 h were analyzed at the ultrastructural
level by electron microscopy. We found a remarkable decrease
in both, the size of inclusions and the number of bacteria
within inclusions, in infected cells treated with iAkt compared
to untreated cells (Figures 8A,B). Interestingly, we noticed
the presence of aberrant bacterial forms in iAkt-treated cells
(Figure 8A), similar to those found under sphingolipids
deprivation or after overexpression of inactive Rab14-GDP
mutant protein (Robertson et al., 2009; Capmany and Damiani,
2010; Capmany et al., 2011). Current findings are consistent with
our previous results, in as much as this pathway is inhibited, the
recruitment of Rab14 to the inclusion decreases and consequently
sphingolipids supply to the inclusion is deficient, generating
the appearance of aberrant bacteria. Next, we confirmed the
detrimental impact on bacterial replication of Akt inhibition
by flow cytometry. Briefly, HeLa cells were infected with GFP-
Ct for 24 h and increasing concentrations of iAkt were added
FIGURE 7 | iAkt effect is overcome by Rab14 WT overexpression. HeLa cells were transfected with either GFP or GFP-Rab14 WT 24 h prior infection (MOI 5). At 2 h
post infection, GFP expressing cells were treated with DMSO or iAkt 5 µM, and GFP-Rab14 WT expressing cells, with iAkt 5 µM until fixation at 24 h pi. Nuclei were
stained with DAPI. Asterisks point out inclusions. Bars represent 10 µm. Representative of two independent experiments.
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FIGURE 8 | Akt inhibition impairs chlamydial replication and infectivity (A) HeLa cells infected with Ct (MOI 1) were treated with DMSO or iAkt (5 µM) from 2 h pi until
fixation at 24 h pi. Cells were processed for transmission electron microscopy (TEM). (B) Quantification of the number of bacteria per inclusion by TEM. At least 30
cells of each experimental condition were analyzed (∗∗∗p < 0.001). (C) HeLa cells were infected with Ct-GFP (MOI 0.5) and treated with DMSO or iAkt (5 or 10 µM)
from 2 h pi until the end of the experimental period. Cells were fixed at 24 h pi and analyzed by flow cytometry. (D) Quantification of green fluorescence (Ct)
associated with infected cells. Results are expressed in relation to untreated infected cells. Data are representative of three independent experiments (∗p < 0.05,
∗∗p < 0.01). (E) HeLa cells infected with Ct (MOI 1) were incubated either with DMSO or increasing doses of iAkt (2, 5, or 10 µM). At 48 h pi, cells were lysed and
the harvested infectious progeny was titrated in serial dilutions on HeLa cells. Bacteria were immunodetected with an anti-MOMP antibody coupled to FITC and
inclusion forming units (IFU) were determined. Bars and the error bars represent mean ± SEM (∗∗p < 0.01, ∗∗∗p < 0.001). Data are representative of three
independent experiments. (F) HeLa cells were transfected with either siRNA-luciferase or siRNA-AS160. After 24 h, cells were infected with Ct (MOI 1) for 48 h
before lysis. Harvested EBs were titrated in serial dilutions on HeLa cells. Bacteria were detected with an anti-MOMP antibody coupled to FITC. Confocal images are
representative of three independent experiments. (G) Infectious progeny harvested from cells was assessed by IFU assays. Results are expressed as IFUs per
microliter. Data are representative of three independent experiments (∗∗p < 0.01).
2 h pi until the end of the experimental period. A decrease in
green fluorescence associated with infected cells correlates with
a reduced amount of GFP-Ct within the cells which is indicative
of less bacterial replication (Figures 8C,D). Concomitantly,
we analyzed the effect of Akt inhibition on the generation of
chlamydial progeny. Thus, we performed Inclusion Forming
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FIGURE 9 | Chlamydia trachomatis hijacks Akt/AS160/Rab14 cascade to acquire Golgi-derived sphingolipids. Ct phosphorylates and recruits pAkt to the inclusion
membrane by one or more cognate effectors (CT effector). Upon Akt activation, AS160 is inactivated by phosphorylation and it is detached from the inclusion
membrane. Hindered AS160 GAP-activity enables Rab14 to remain in its GTP-bound membrane-associated active form. This, in turn, favors the arrival to chlamydial
inclusions of sphingolipids synthesized at the Golgi apparatus through a Rab14-controlled vesicular transport.
Units (IFUs) assays in the absence or presence of increasing
concentrations of iAkt to evaluate the contribution of this kinase
on the yield of infectious particles. Briefly, HeLa cells were
infected with C. trachomatis and 2 h later, cells were incubated
with increasing iAkt doses or DMSO and lysed at 48 h pi to
harvest infectious EBs. Then, cell lysates were used to infect
monolayers of HeLa cells in serial dilutions. After 24 h, these new
round of infected cells were fixed and the number of inclusions
was quantified by confocal microscopy. Inclusions were detected
with an anti-MOMP antibody coupled to FITC and chlamydial
infectious progeny was calculated. As expected, inhibition of Akt
significantly reduced bacterial infectivity (Figure 8E). To further
confirm the involvement of AS160 on chlamydial replication
and infectivity, HeLa cells, previously transfected with siRNA-
AS160 or siRNA-Luciferase, were then infected with GFP-Ct for
48 h before cell lysis. Then, EBs harvested from cell lysates were
titrated in serial dilutions on HeLa cells (Figures 8F,G). Although
AS160 silencing did not affect bacterial internalization, it had a
detrimental effect on bacterial replication, as observed in images
taken by confocal microscopy (Figure 8F). As expected, AS160
depletion significantly decreased the yield of infectious particles
assessed by IFU assays (Figure 8G).
Taken together, our findings indicate that C. trachomatis-
activated Akt/AS160/Rab14 pathway is critical to ensure
sphingolipids supply to chlamydial inclusions and consequently
to warrant chlamydial replication and development.
Therefore, inhibition of Akt or downstream members of
the Akt/AS160/Rab14 axis may limit chlamydial infection.
DISCUSSION
Chlamydia trachomatis, like other obligate intracellular bacteria,
needs the host machinery to replicate and survive (Bastidas
et al., 2013; Damiani et al., 2014). Lipids acquisition from host
cells is fundamental for both bacterial replication and inclusion
membrane growth. Actually, C. trachomatis is able to recruit
host lipid synthesis machinery at the inclusion membrane (Derré
et al., 2011; Elwell et al., 2011) and to piracy lipids from TGN-
derived vesicles (Hackstadt et al., 1996; Carabeo et al., 2003),
multivesicular bodies (Beatty, 2006, 2008; Gambarte Tudela et al.,
2015) and lipid droplets (Kumar et al., 2006; Cocchiaro et al.,
2008). An extensively exploited strategy used by this bacterium is
the recruitment of specific Rab proteins to subvert host vesicular
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trafficking (Damiani et al., 2014); nonetheless, the molecular
mechanisms underlying the recruitment of Rab proteins are
largely unknown. We have reported that C. trachomatis intercepts
Rab14-vesicles, derived from the Golgi apparatus and in transit
to the plasma membrane, to acquire endogenously synthesized
sphingolipids (Capmany and Damiani, 2010; Capmany et al.,
2011). Here, we showed the participation of Akt/AS160 signaling
pathway in sphingolipids delivery to chlamydial inclusions. Our
working model is displayed in Figure 9. This is the first report
to link a phosphorylation cascade, initiated by this bacterium,
and the recruitment of a Rab protein to the inclusion membrane
with the subsequent redirection of Golgi-derived sphingolipids to
chlamydial inclusion.
Recent evidence pointed out that TepP (translocated early
phospho-protein), a chlamydial effector located at the inclusion
membrane, recruits PI3K and the signaling adaptor protein CrkL
forming a complex. TepP is a protein involved in bacterial
replication and activation of type I IFN genes. Although
translocation of TepP is not related to Akt activation, it could
be involved in its recruitment (Carpenter et al., 2017). PI3K
acts upstream from Akt in this signaling pathway, therefore,
this report reinforces our findings. In this study, we found Akt
is phosphorylated throughout the entire developmental cycle,
standing out three phosphorylation peaks: at the beginning
(2 h pi), at the middle (8 h pi), and at late stages (36 h
pi) of the cycle. At the peaks, pAkt doubled or tripled the
level of Akt phosphorylation in uninfected cells. However,
total Akt expression remained unaltered in Chlamydia-infected
cells. Furthermore, we showed a strong redistribution of
endogenous pAkt after infection, which concentrated at the
perinucleus where the bacteria were located. In agreement,
several reports account for Akt phosphorylation after chlamydial
infection, however, differences in phosphorylation dynamics
could be due to different Chlamydia species or serovars,
experimental conditions or host cell type (Verbeke et al., 2006;
Rajalingam et al., 2008; Gurumurthy et al., 2010; Patel et al.,
2014; Subbarayal et al., 2015). PI3K/Akt signaling pathway
participates in multiple cellular processes such as apoptosis
resistance and cell survival, glucose metabolism, cell growth
and proliferation, actin recruitment and phagosome formation,
among others (Innocenti et al., 2003; Engelman et al., 2006;
Yeo et al., 2015; Zhao et al., 2015). We focused our efforts to
elucidate the link between PI3K/Akt cascade and intracellular
transport of sphingolipids in C. trachomatis-infected cells.
One of the substrates of Akt is AS160 (Akt Substrate of
160 kDa), a GTPase Activating Protein (GAP) for several
Rabs. In general, Rab GTP/GDP cycling is regulated by a
delicate equilibrium between GTPase activating proteins (GAPs)
and guanine nucleotide exchange factors (GEFs), controlling
Rab subcellular localization and displacement between cellular
compartments. Proper translocation from a donor to an acceptor
membranous compartment requires a fine tune controlled
GTP/GDP cycling (Voss et al., 2019). Akt phosphorylates
and, consequently, inactivates AS160 when they are both
associated to the same membrane (Larance et al., 2005;
Gonzalez and McGraw, 2009). Phosphorylated AS160 detaches
from membranes and loses its GAP activity; hence, the
target Rab remains in its active, membrane-associated, GTP-
bound state for longer (Mîinea et al., 2005; Thong et al.,
2007). By membrane/cytosol fractionation, we confirmed that
Akt activation in the context of C. trachomatis infection
triggers AS160 phosphorylation and its release from membranes.
Consequently, Akt inhibition increases AS160 association with
membranes where it enhances the intrinsic Rab GTPase activity
of the cognate Rab.
AS160 is GAP for Rab2, Rab8A, Rab10, and Rab14 (Kane
et al., 2002; Sano et al., 2003; Mîinea et al., 2005). Rab10
associates with chlamydial inclusions in a species-dependent
manner, only being found on Chlamydia pneumoniae inclusions
(Cortes et al., 2007). At present, Rab2 and Rab8 involvement
in chlamydial infections have not been investigated. Since
AS160 modulates Rab14 GTP/GDP cycling and C. trachomatis
hijacks Rab14-controlled intracellular trafficking; an interesting
challenge was to determine if there was a relationship between
Akt activation and vesicular transport in C. trachomatis-infected
cells. We observed that AS160, like Akt, is phosphorylated
during the entire developmental cycle, but unlike Akt, AS160
displays a steady level of phosphorylation over time. This
may indicate a phosphorylation/dephosphorylation turnover that
favors AS160 phosphorylated form, or it could be likely attributed
to inactivation of a putative AS160 phosphatase byC. trachomatis.
Alternatively, other kinases, besides Akt, may be involved in
AS160 phosphorylation. Actually, it has been described that
PKC and AMPK phosphorylate AS160 in muscle cells to induce
GLUT4 translocation (Thong et al., 2007). Nevertheless, our
findings indicate that C. trachomatis-induced Akt activation is
the main via of AS160 phosphorylation; since pAS160 drastically
decreased after Akt inhibition. We confirmed these results
by confocal microscopy. In infected cells, AS160 displayed
a cytosolic distribution, as expected by its phosphorylation
provoked by activated Akt; accordingly, AS160 was recruited
to chlamydial inclusions under iAkt treatment. Moreover,
we found Rab14 associated with the inclusion membrane in
those domains where AS160 was not present. In agreement,
treatment of infected cells with an allosteric Akt inhibitor (iAkt)
hindered Rab14 recruitment to chlamydial inclusions in a dose-
dependent manner.
Akt/AS160/Rab14 axis has been extensively studied in
adipocytes and muscle cells, in which, insulin stimulus results
in GLUT4 translocation to the plasma membrane. Signaling
cascade begins with Akt phosphorylation which in turn
phosphorylates and inactivates AS160, favoring Rab14-controlled
GLUT4 translocation (Kane et al., 2002; Sano et al., 2003;
Mîinea et al., 2005; Ishikura et al., 2006; Klip et al., 2014).
Similarly, through the activation of the same signaling pathway,
Similiki Forest virus, Ross River virus and Mycobacterium
tuberculosis alter glucose and lipid metabolism of the host
cell by the translocation of some GLUT isoforms from an
intracellular pool to the plasma membrane (Dasgupta and Rai,
2018; Mazzon et al., 2018). In line with these findings, we
have previously shown that GTP/GDP cycling is necessary to
accomplish Rab14 function since the GDP-bound mutant (GFP-
Rab14 S25N) is retained at the Golgi apparatus in infected cells
(Capmany and Damiani, 2010). Furthermore, Rab14 silencing
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reduces chlamydial infectious progeny in a similar extent to
overexpression of the inactive GDP-bound mutant form of Rab14
(Capmany and Damiani, 2010).
Our studies showed that Akt inhibition impairs C. trachomatis
growth and replication denoted by a decrease in chlamydial
inclusion size, bacterial multiplication, and infectivity assessed
by different experimental approaches like confocal microscopy,
electron microscopy, flow cytometry, and IFU assays. Similar
results were obtained in AS160-depleted cells, confirming that
Rab14 GTP/GDP cycling is necessary for optimal bacterial fitness.
Supporting these findings, it has been reported that Salmonella
typhimurium and Staphylococcus aureus avoid degradation
by manipulating Akt/AS160/Rab14 axis to prevent or delay
phagosome-lysosome fusion (Kuijl et al., 2007; Casanova, 2017;
Lacoma et al., 2017).
Summarizing, we have determined that the activation of
Akt induced by chlamydial infection leads to phosphorylation
and inactivation of AS160 and the subsequent recruitment to
inclusions of Rab14. The remaining question to address was
about the benefit that C. trachomatis obtains by activating
the Akt/AS160/Rab14 pathway. Giving consideration to our
previous results, which demonstrates that C. trachomatis usurps
Rab14-controlled vesicular transport to piracy Golgi-derived
sphingolipids (Capmany and Damiani, 2010), and these new
results that show an impaired recruitment of Rab14 after iAkt
treatment in a dose-dependent manner, we hypothesized that
C. trachomatis could activate Akt/AS160 pathway to ensure
sphingolipids delivery to chlamydial inclusions. By the use of
BODIPY-Ceramide as a sphingolipid precursor, we observed
that Akt inhibition caused the retention of these lipids at the
periphery of inclusions, particularly at the Golgi apparatus.
Consistently, a reduced amount of sphingolipids were found
inside inclusions after iAkt treatment in a dose-dependent
manner. By electron microscopy, we observed not only smaller
inclusions with less Chlamydia but also the appearance of
aberrant bacterial forms after Akt inhibition. Similarly, aberrant
bacteria were also generated by lipid deprivation, overexpression
of inactive GDP-bound Rab14 mutant or Rab14 silencing (van
Ooij et al., 2000; Capmany and Damiani, 2010). Involvement
of Akt activity in the control of Rab14-mediated delivery of
sphingomyelin to the chlamydial inclusions was confirmed in
a rescue assay, in which overexpression of Rab14 overcame
iAkt effects. Altogether, the activation of Akt not only facilitates
C. trachomatis internalization and inhibition of the host cell
apoptosis but also promotes the redirecting of post-Golgi vesicles
full of sphingolipids to chlamydial inclusions. In addition, AS160
depletion generated chlamydial inclusions of smaller size and
caused sphingolipids retention at the Golgi apparatus, confirming
that impairment of GTP/GDP cycling reduces Rab14-controlled
sphingolipids delivery to chlamydial inclusions. Further, we
demonstrated that ceramide to sphingomyelin conversion was
unaffected by Akt inhibitor or AS160 silencing, therefore, the
decrease in the amount of sphingolipids within inclusions is a
consequence of its retention at the Golgi apparatus, constituting
a transport defect and not a metabolic alteration.
In line with our findings, it has been shown that
S. typhimurium effector SopB promotes intracellular
survival by blocking phagosome-lysosome fusion through
the Akt/AS160/Rab14 pathway (Kuijl et al., 2007). Furthermore,
multidrug-resistant M. tuberculosis usurps the same signaling
pathway to impede phagosome maturation (Lacoma et al.,
2017). The Akt inhibitor used in the present research impaired
infections caused by these intracellular pathogens and opened a
new road for the treatment of these difficult to eradicate bacteria
(Kuijl et al., 2007). Many viruses have evolved mechanisms to
manipulate host cell signaling pathways to generate a permissive
intracellular environment for replication. Among them,
herpesviruses (VHS) which express multiple proteins that hijack
PI3K/Akt signaling pathway to optimize virus entry, replication,
latency, reactivation, and modulation of host immune responses
(Cheshenko et al., 2013; Liu and Cohen, 2015). Interestingly,
miltefosine, which blocks Akt phosphorylation, inhibits VHS
plaque formation (Cheshenko et al., 2013). In addition, human
immunodeficiency virus (HIV) Tat protein promotes the stress-
induced activation of the PI3K/Akt signaling cascade to favor
survival of infected macrophages. Hence, PI3K/Akt inhibitors
could be effective to eliminate HIV-infected macrophages by
apoptosis (Chugh et al., 2008).
Current antibiotics directly target microorganisms rather than
pathogen–host cell relationship. However, the emergence of
multidrug-resistant bacteria pushes up the development of new
pharmacological tools that complement actual therapies. A major
challenge in the generation of new antimicrobial agents is the
poor knowledge of the complex interaction between bacteria and
host cells that leads to intracellular survival of the microorganism.
In this regard, substantial advances have been achieved in the
use of inhibitors of the PI3K/Akt pathway that were initially
designed as anti-tumoral drugs to limit infections. Our findings
indicate that an allosteric isoform-specific Akt inhibitor, iAkt,
is effective to restrict C. trachomatis growth and replication, to
limit chlamydial inclusion development and to reduce bacterial
progeny and overall infectivity in a dose-dependent manner.
Furthermore, downsizing of inclusions and impaired bacterial
replication by iAkt are not attributable to direct drug toxicity
to the cells or the bacteria since iAkt effects are reversible;
therefore, Akt inhibitor acts as a bacteriostatic agent rather
than a bactericidal one at the doses assayed. Further research is
necessary to fully characterize chlamydial proteins involved in
the manipulation of Akt/AS160/Rab14 cascade in order to design
specific targeted molecular therapies to control infections caused
by this widespread intracellular pathogen.
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